Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition

Objective To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution t...

Full description

Saved in:
Bibliographic Details
Published inArthritis and rheumatism Vol. 44; no. 2; pp. 307 - 314
Main Authors Pascual, M., Nieto, A., López‐Nevot, M. A., Ramal, L., Matarán, L., Caballero, A., Alonso, A., Martín, J., Zanelli, E.
Format Journal Article
LanguageEnglish
Published New York John Wiley & Sons, Inc 01.02.2001
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition. Methods One hundred sixty RA patients and 153 healthy controls were typed for HLA–DRB1 and –DQB1 using high‐resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA‐positive DRB1 alleles according to the RAP model. Results DQ3 (DQB1*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE‐positive DRB1 alleles. DQ3/3‐homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001‐carrying haplotype; no DRB1*1001‐homozygous patients were observed. DRB1*0401 played a unique role in the contribution of DQ3–DR4 haplotypes to RA, in spite of its low frequency in southern Spain. Conclusion The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3–DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA–DQ and –DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.
AbstractList Objective To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition. Methods One hundred sixty RA patients and 153 healthy controls were typed for HLA–DRB1 and –DQB1 using high‐resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA‐positive DRB1 alleles according to the RAP model. Results DQ3 (DQB1*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE‐positive DRB1 alleles. DQ3/3‐homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001‐carrying haplotype; no DRB1*1001‐homozygous patients were observed. DRB1*0401 played a unique role in the contribution of DQ3–DR4 haplotypes to RA, in spite of its low frequency in southern Spain. Conclusion The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3–DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA–DQ and –DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.
To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.OBJECTIVETo evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition.One hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model.METHODSOne hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model.DQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain.RESULTSDQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain.The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.CONCLUSIONThe low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.
To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare the value of the shared epitope (SE) and RA protection (RAP) models in accounting for the HLA class II region's contribution to RA predisposition. One hundred sixty RA patients and 153 healthy controls were typed for HLA-DRB1 and -DQB1 using high-resolution DNA techniques. Distributions of predisposing DRB1 alleles in patients and control subjects according to the SE model were compared with distributions of predisposing DQ and protective DERAA-positive DRBI alleles according to the RAP model. DQ3 (DQBI*03 and *04 combined with DQA1*03) and DQ5 (DQB1*0501/DQA1*0101) alleles predisposed individuals to RA independently of SE-positive DRB1 alleles. DQ3/3-homozygous individuals had the strongest risk of developing RA. DQ3 molecules predisposed to RA more than did DQ5 molecules. The weaker predisposition mediated by DQ5 included the DRB1*1001-carrying haplotype; no DRB1*1001-homozygous patients were observed. DRBI*0401 played a unique role in the contribution of DQ3-DR4 haplotypes to RA, in spite of its low frequency in southern Spain. The low prevalences of RA and of mild disease observed in Spain, and in southern Europe in general, can be explained in great part by the low frequency of DQ3-DR4 haplotypes, especially those carrying DRB1*0401. However, the overall distribution of HLA-DQ and -DR alleles in RA patients compared with control subjects is similar to that in other European and North American populations. A model involving both DQ and DR can best account for the contribution of HLA to RA.
Author Caballero, A.
Martín, J.
Alonso, A.
Pascual, M.
Matarán, L.
Zanelli, E.
Nieto, A.
López‐Nevot, M. A.
Ramal, L.
Author_xml – sequence: 1
  givenname: M.
  surname: Pascual
  fullname: Pascual, M.
– sequence: 2
  givenname: A.
  surname: Nieto
  fullname: Nieto, A.
– sequence: 3
  givenname: M. A.
  surname: López‐Nevot
  fullname: López‐Nevot, M. A.
– sequence: 4
  givenname: L.
  surname: Ramal
  fullname: Ramal, L.
– sequence: 5
  givenname: L.
  surname: Matarán
  fullname: Matarán, L.
– sequence: 6
  givenname: A.
  surname: Caballero
  fullname: Caballero, A.
– sequence: 7
  givenname: A.
  surname: Alonso
  fullname: Alonso, A.
– sequence: 8
  givenname: J.
  surname: Martín
  fullname: Martín, J.
– sequence: 9
  givenname: E.
  surname: Zanelli
  fullname: Zanelli, E.
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=930111$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11229460$$D View this record in MEDLINE/PubMed
BookMark eNqVkc9v0zAUgC00xLrBv4AsISF2SHm2kzruEFJVfqxaRcUYZ8tJXlajNA52oqnX_eU4tIwLF062n773HfydkZPWtUiIZDBlAPwty7hKgAn2hgMw4BdpOufvBMj5fLH6kCy-3KTyvZjCdLm55Mn1EzJ53DghEwBIE5EpdkrOQvgRn1xk4hk5ZYxzlc5gQh5utjjsTO9sRY3vt972NlDb0uCGfou-pd86Y9s5vXX3xlcUm6G0lemta6mrqaFDa-u9be-odw2Oo7hFr9YLWjYmBLpaUY93Ix2dlQ1oAtLOY7x2LtjR85w8rU0T8MXxPCffP328XV4l683n1XKxTkquZjLBQiBiUbEyg1KirPK8YJAKlXPBwOR5VoNQRZ4JY1glISv4TBSpUspUuRBSnJPXB2_n3c8BQ693NpTYNKZFNwQtYSYUlzyCL4_gUOyw0p23O-P3-s-vReDVETChNE3tTVva8MgpAYyxSG0OVOldCB7rvyLQY109ttJjK32oq9NUcx3rah3r6t91tdCgl5s4v47GrwfjvW1w_x-6f9kOA_ELmhKzjA
CODEN ARHEAW
Cites_doi 10.1093/rheumatology/37.2.165
10.1038/nm0396-306
10.1111/j.1399-0039.1994.tb02347.x
10.1046/j.1365-2370.1999.00135.x
10.1002/art.1780310302
10.1016/0167-5699(95)80181-2
10.1002/art.1780350306
10.1093/intimm/8.5.757
10.1084/jem.180.4.1559
10.1172/JCI108382
10.1002/eji.1830270634
10.1002/art.1780301102
10.1016/S0198-8859(98)00101-3
10.1111/j.1399-0039.1994.tb02291.x
10.1093/rheumatology/36.3.322
10.1073/pnas.93.5.1814
10.1016/S0065-2776(08)60456-3
10.1136/ard.40.3.299
10.1080/03009749850154447
10.1007/s002510050450
10.1002/art.1780350705
10.1136/bmj.283.6302.1287
10.1093/rheumatology/39.8.844
10.1002/art.1780340107
10.1084/jem.183.1.27
10.1016/S0198-8859(99)00059-2
10.1016/S0889-857X(21)00149-6
10.1111/j.1399-0039.1990.tb01825.x
10.1016/0198-8859(95)00165-4
10.1016/S0065-2776(08)60563-5
10.1111/j.1399-0039.1996.tb02515.x
10.1002/art.1780370125
ContentType Journal Article
Copyright Copyright © 2001 by the American College of Rheumatology
2001 INIST-CNRS
Copyright_xml – notice: Copyright © 2001 by the American College of Rheumatology
– notice: 2001 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1529-0131
EndPage 314
ExternalDocumentID 11229460
930111
10_1002_1529_0131_200102_44_2_307__AID_ANR47_3_0_CO_2_K
ANR47
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Europe
Spain
GeographicLocations_xml – name: Spain
GrantInformation_xml – fundername: Plan Andaluz de Investigación
  funderid: CTS‐180
– fundername: Plan Nacional de I+D (CICYT)
  funderid: SAF97‐0046; SAF00‐213
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
10A
1CY
1KJ
1L6
1OB
1OC
1ZS
23N
24P
31~
33P
3O-
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52W
52X
53G
5GY
5RE
66C
6J9
6P2
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAQQT
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBTR
ADEOM
ADIZJ
ADMGS
ADNMO
ADOZA
ADZCM
ADZOD
AEEZP
AEIGN
AEIMD
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZFZN
BDRZF
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J5H
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
M65
MEWTI
MJL
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N4W
N9A
NNB
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q11
QB0
QRW
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RXW
RYL
SAMSI
SJN
SUPJJ
SV3
TAE
TEORI
TWZ
UB1
V2E
V8K
V9Y
VH1
W8V
WH7
WIB
WIH
WIJ
WIK
WIN
WJL
WOW
WQJ
WRC
WUP
WXI
WXSBR
X6Y
X7M
XG1
XPP
XV2
YFH
YOC
ZGI
ZXP
ZZTAW
~IA
~WT
AAFWJ
AAYXX
AGQPQ
AGYGG
CITATION
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
VXZ
7X8
ID FETCH-LOGICAL-c2967-eb3eeebd1c50c7e7d88b1043982310a885f039b853aa1d705b263b4999ad83373
IEDL.DBID DR2
ISSN 0004-3591
IngestDate Thu Jul 10 22:36:27 EDT 2025
Wed Feb 19 01:28:43 EST 2025
Mon Jul 21 09:12:11 EDT 2025
Tue Jul 01 02:40:35 EDT 2025
Wed Jan 22 16:48:51 EST 2025
IsPeerReviewed false
IsScholarly false
Issue 2
Keywords Human
Immunopathology
HLA-System
Pathogenesis
Diseases of the osteoarticular system
Class II histocompatibility antigen
Autoimmune disease
Exploration
Inflammatory joint disease
Genetic determinism
Epidemiology
Symptomatology
Chronic
DNA
Rheumatoid arthritis
Public health
Polymorphism
Language English
License http://doi.wiley.com/10.1002/tdm_license_1.1
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2967-eb3eeebd1c50c7e7d88b1043982310a885f039b853aa1d705b263b4999ad83373
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 11229460
PQID 70639272
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_70639272
pubmed_primary_11229460
pascalfrancis_primary_930111
crossref_primary_10_1002_1529_0131_200102_44_2_307__AID_ANR47_3_0_CO_2_K
wiley_primary_10_1002_1529_0131_200102_44_2_307_AID_ANR47_3_0_CO_2_K_ANR47
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate February 2001
PublicationDateYYYYMMDD 2001-02-01
PublicationDate_xml – month: 02
  year: 2001
  text: February 2001
PublicationDecade 2000
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: Hoboken , NJ
– name: United States
PublicationTitle Arthritis and rheumatism
PublicationTitleAlternate Arthritis Rheum
PublicationYear 2001
Publisher John Wiley & Sons, Inc
Wiley
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley
References 1998; 27
1998; 48
1981; 283
1987; 30
1990; 36
1991; 34
1995; 16
1999; 26
1992; 18
1996; 183
1996; 93
1992; 19
1997; 27
1992; 35
1988; 31
1999; 60
1981; 40
1994; 43
1992; 96
1998; 68
1998; 37
1976; 57
2000; 39
1994; 180
1997; 36
1995; 22
1994; 56
1994; 37
1996; 47
1996; 46
1996; 2
1996; 8
Seidl (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB28) 1999; 26
Maffei (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB33) 1997; 27
Arnett (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB24) 1988; 31
Van der Horst-Bruinsma (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB18) 1999; 60
Das (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB17) 1999; 60
Nepom (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB32) 1998; 68
Willkens (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB11) 1991; 34
Boey (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB8) 1992; 19
Auger (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB36) 1996; 2
Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB13) 1995; 16
Wakitani (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB29) 1998; 27
Taneja (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB25) 1996; 46
Ronda (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB19) 1994; 37
Taneja (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB6) 1992; 96
Svejgaard (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB27) 1994; 43
Matsushita (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB34) 1996; 8
Winchester (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB2) 1994; 56
Nabozny (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB15) 1996; 183
Gregersen (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB9) 1987; 30
Gonzalez-Gay (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB12) 1994; 180
Ollier (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB1) 1992; 18
Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB16) 1996; 93
Sanchez (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB10) 1990; 36
Stastny (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB3) 1976; 57
Maeda (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB7) 1981; 40
Zanelli (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB14) 1998; 48
Benazet (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB22) 1995; 22
Stavropoulos-Giokas (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB31) 1999; 60
McDonagh (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB35) 1997; 36
Woodrow (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB4) 1981; 283
González (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB30) 1992; 35
Balsa (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB23) 2000; 39
De Juan (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB5) 1994; 43
Martinez-Laso (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB26) 1996; 47
Salvarani (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB20) 1998; 37
Drosos (10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB21) 1992; 35
References_xml – volume: 48
  start-page: 394
  year: 1998
  end-page: 401
  article-title: An extended HLA‐DQ‐DR haplotype rather than DRB1 alone contributes to RA predisposition
  publication-title: Immunogenetics
– volume: 40
  start-page: 299
  year: 1981
  end-page: 302
  article-title: HLA‐DR4 and rheumatoid arthritis in Japanese people
  publication-title: Ann Rheum Dis
– volume: 68
  start-page: 315
  year: 1998
  end-page: 32
  article-title: Major histocompatibility complex‐directed susceptibility to rheumatoid arthritis
  publication-title: Adv Immunol
– volume: 60
  start-page: 152
  year: 1999
  end-page: 8
  article-title: HLA‐DQ‐associated predisposition to and dominant HLA‐DR‐associated protection against rheumatoid arthritis
  publication-title: Hum Immunol
– volume: 31
  start-page: 315
  year: 1988
  end-page: 24
  article-title: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 60
  start-page: 575
  year: 1999
  end-page: 82
  article-title: An HLA‐DRB1*0402 derived peptide (HV3 65‐79) prevents collagen‐induced arthritis in HLA‐DQ8 transgenic mice
  publication-title: Hum Immunol
– volume: 183
  start-page: 27
  year: 1996
  end-page: 37
  article-title: HLA‐DQ8 transgenic mice are highly susceptible to collagen‐induced arthritis: a novel model for human polyarthritis
  publication-title: J Exp Med
– volume: 36
  start-page: 322
  year: 1997
  end-page: 7
  article-title: Compound heterozygosity for the shared epitope and the risk and severity of rheumatoid arthritis in extended pedigrees
  publication-title: Br J Rheumatol
– volume: 2
  start-page: 306
  year: 1996
  end-page: 10
  article-title: HLA‐DR4 and HLA‐DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70‐kD heat shock proteins
  publication-title: Nat Med
– volume: 19
  start-page: 1517
  year: 1992
  end-page: 9
  article-title: HLA in Singapore Chinese with rheumatoid arthritis
  publication-title: J Rheumatol
– volume: 57
  start-page: 1148
  year: 1976
  end-page: 57
  article-title: Mixed lymphocyte cultures in rheumatoid arthritis
  publication-title: J Clin Invest
– volume: 35
  start-page: 282
  year: 1992
  end-page: 9
  article-title: Novel genetic markers of rheumatoid arthritis in Chilean patients, by DR serotyping and restriction fragment length polymorphism analysis
  publication-title: Arthritis Rheum
– volume: 27
  start-page: 381
  year: 1998
  end-page: 2
  article-title: The homozygote of HLA‐DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese
  publication-title: Scand J Rheumatol
– volume: 18
  start-page: 741
  year: 1992
  end-page: 59
  article-title: Population genetics of rheumatoid arthritis
  publication-title: Rheum Dis Clin North Am
– volume: 35
  start-page: 745
  year: 1992
  end-page: 8
  article-title: Rheumatoid arthritis in Greek and British patients: a comparative clinical, radiologic, and serologic study
  publication-title: Arthritis Rheum
– volume: 37
  start-page: 165
  year: 1998
  end-page: 9
  article-title: HLA‐DRB1 alleles associated with rheumatoid arthritis in northern Italy: correlation with disease severity
  publication-title: Br J Rheumatol
– volume: 43
  start-page: 18
  year: 1994
  end-page: 27
  article-title: HLA and disease associations: detecting the strongest association
  publication-title: Tissue Antigens
– volume: 60
  start-page: S48
  issue: Suppl 1
  year: 1999
  article-title: The shared epitope versus DR/DQ haplotype hypothesis in rheumatoid arthritis in Greeks
  publication-title: Hum Immunol
– volume: 26
  start-page: 19
  year: 1999
  end-page: 27
  article-title: HLA‐DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations
  publication-title: Eur J Immunogenet
– volume: 180
  start-page: 1559
  year: 1994
  end-page: 64
  article-title: Protective role of major histocompatibility complex class II Eb transgene on collagen‐induced arthritis
  publication-title: J Exp Med
– volume: 37
  start-page: 147
  year: 1994
  end-page: 8
  article-title: Differences between Spanish and British patients in the severity of rheumatoid arthritis: comment on the article by Drosos et al
  publication-title: Arthritis Rheum
– volume: 16
  start-page: 274
  year: 1995
  end-page: 8
  article-title: Could HLA‐DRB1 be the protective locus in rheumatoid arthritis?
  publication-title: Immunol Today
– volume: 39
  start-page: 844
  year: 2000
  end-page: 9
  article-title: Class II MHC antigens in early rheumatoid arthritis in Bath (UK) and Madrid (Spain)
  publication-title: Rheumatology
– volume: 34
  start-page: 43
  year: 1991
  end-page: 7
  article-title: Association of HLA–Dw16 with rheumatoid arthritis in Yakima Indians: further evidence for the “shared epitope” hypothesis
  publication-title: Arthritis Rheum
– volume: 30
  start-page: 1205
  year: 1987
  end-page: 13
  article-title: The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
  publication-title: Arthritis Rheum
– volume: 36
  start-page: 174
  year: 1990
  end-page: 6
  article-title: HLA‐DRw10 confers the highest susceptibility to rheumatoid arthritis in a Spanish population
  publication-title: Tissue Antigens
– volume: 27
  start-page: 1549
  year: 1997
  end-page: 56
  article-title: Differential expression of insulin‐dependent diabetes mellitus‐associated HLA‐DQA1 alleles in vivo
  publication-title: Eur J Immunol
– volume: 8
  start-page: 757
  year: 1996
  end-page: 64
  article-title: HLA‐DQ‐binding peptide motifs: comparative binding analysis of type II collagen‐derived peptides to DR and DQ molecules of rheumatoid arthritis‐susceptible and non‐susceptible haplotypes
  publication-title: Int Immunol
– volume: 93
  start-page: 1814
  year: 1996
  end-page: 9
  article-title: Immune response of HLA‐DQ8 transgenic mice to peptides from the third hypervariable region of HLA‐DRB1 correlates with predisposition to rheumatoid arthritis
  publication-title: Proc Natl Acad Sci U S A
– volume: 47
  start-page: 63
  year: 1996
  end-page: 71
  article-title: HLA‐DR and DQ polymorphism in Ashkenazi and non‐Ashkenazi Jews: comparison with other Mediterraneans
  publication-title: Tissue Antigens
– volume: 56
  start-page: 389
  year: 1994
  end-page: 466
  article-title: The molecular basis of susceptibility to rheumatoid arthritis
  publication-title: Adv Immunol
– volume: 22
  start-page: 607
  year: 1995
  end-page: 10
  article-title: HLA‐DRB1 alleles associated with rheumatoid arthritis in southern France: absence of extraarticular disease despite expression of the shared epitope
  publication-title: J Rheumatol
– volume: 96
  start-page: 16
  year: 1992
  end-page: 23
  article-title: Protective & risk DR phenotypes in Asian Indian patients with rheumatoid arthritis
  publication-title: Indian J Med Res
– volume: 43
  start-page: 320
  year: 1994
  end-page: 3
  article-title: Differential association with rheumatoid arthritis (RA) in Basques: high frequency of DR1 and DR10 and lack of association with HLA‐DR4 or any of its subtypes
  publication-title: Tissue Antigens
– volume: 46
  start-page: 35
  year: 1996
  end-page: 41
  article-title: Polymorphism of HLA‐DRB, ‐DQA1, and ‐DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001
  publication-title: Hum Immunol
– volume: 283
  start-page: 1287
  year: 1981
  end-page: 8
  article-title: DR antigens and rheumatoid arthritis: a study in two populations
  publication-title: Br Med J
– volume: 96
  start-page: 16
  year: 1992
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB6
  publication-title: Indian J Med Res
– volume: 37
  start-page: 165
  year: 1998
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB20
  publication-title: Br J Rheumatol
  doi: 10.1093/rheumatology/37.2.165
– volume: 2
  start-page: 306
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB36
  publication-title: Nat Med
  doi: 10.1038/nm0396-306
– volume: 43
  start-page: 320
  year: 1994
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB5
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1994.tb02347.x
– volume: 26
  start-page: 19
  year: 1999
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB28
  publication-title: Eur J Immunogenet
  doi: 10.1046/j.1365-2370.1999.00135.x
– volume: 31
  start-page: 315
  year: 1988
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB24
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780310302
– volume: 16
  start-page: 274
  year: 1995
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB13
  publication-title: Immunol Today
  doi: 10.1016/0167-5699(95)80181-2
– volume: 22
  start-page: 607
  year: 1995
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB22
  publication-title: J Rheumatol
– volume: 35
  start-page: 282
  year: 1992
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB30
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780350306
– volume: 60
  start-page: s48
  year: 1999
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB31
  publication-title: Hum Immunol
– volume: 8
  start-page: 757
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB34
  publication-title: Int Immunol
  doi: 10.1093/intimm/8.5.757
– volume: 180
  start-page: 1559
  year: 1994
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB12
  publication-title: J Exp Med
  doi: 10.1084/jem.180.4.1559
– volume: 57
  start-page: 1148
  year: 1976
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB3
  publication-title: J Clin Invest
  doi: 10.1172/JCI108382
– volume: 27
  start-page: 1549
  year: 1997
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB33
  publication-title: Eur J Immunol
  doi: 10.1002/eji.1830270634
– volume: 30
  start-page: 1205
  year: 1987
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB9
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780301102
– volume: 60
  start-page: 152
  year: 1999
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB18
  publication-title: Hum Immunol
  doi: 10.1016/S0198-8859(98)00101-3
– volume: 43
  start-page: 18
  year: 1994
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB27
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1994.tb02291.x
– volume: 36
  start-page: 322
  year: 1997
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB35
  publication-title: Br J Rheumatol
  doi: 10.1093/rheumatology/36.3.322
– volume: 93
  start-page: 1814
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB16
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.5.1814
– volume: 56
  start-page: 389
  year: 1994
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB2
  publication-title: Adv Immunol
  doi: 10.1016/S0065-2776(08)60456-3
– volume: 40
  start-page: 299
  year: 1981
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB7
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.40.3.299
– volume: 27
  start-page: 381
  year: 1998
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB29
  publication-title: Scand J Rheumatol
  doi: 10.1080/03009749850154447
– volume: 48
  start-page: 394
  year: 1998
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB14
  publication-title: Immunogenetics
  doi: 10.1007/s002510050450
– volume: 35
  start-page: 745
  year: 1992
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB21
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780350705
– volume: 283
  start-page: 1287
  year: 1981
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB4
  publication-title: Br Med J
  doi: 10.1136/bmj.283.6302.1287
– volume: 39
  start-page: 844
  year: 2000
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB23
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/39.8.844
– volume: 34
  start-page: 43
  year: 1991
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB11
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780340107
– volume: 183
  start-page: 27
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB15
  publication-title: J Exp Med
  doi: 10.1084/jem.183.1.27
– volume: 60
  start-page: 575
  year: 1999
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB17
  publication-title: Hum Immunol
  doi: 10.1016/S0198-8859(99)00059-2
– volume: 18
  start-page: 741
  year: 1992
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB1
  publication-title: Rheum Dis Clin North Am
  doi: 10.1016/S0889-857X(21)00149-6
– volume: 36
  start-page: 174
  year: 1990
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB10
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1990.tb01825.x
– volume: 46
  start-page: 35
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB25
  publication-title: Hum Immunol
  doi: 10.1016/0198-8859(95)00165-4
– volume: 68
  start-page: 315
  year: 1998
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB32
  publication-title: Adv Immunol
  doi: 10.1016/S0065-2776(08)60563-5
– volume: 47
  start-page: 63
  year: 1996
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB26
  publication-title: Tissue Antigens
  doi: 10.1111/j.1399-0039.1996.tb02515.x
– volume: 37
  start-page: 147
  year: 1994
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB19
  publication-title: Arthritis Rheum
  doi: 10.1002/art.1780370125
– volume: 19
  start-page: 1517
  year: 1992
  ident: 10.1002/1529-0131(200102)44:2<307::AID-ANR47>3.0.CO;2-K-BIB8
  publication-title: J Rheumatol
SSID ssj0002353
Score 1.3693492
Snippet Objective To evaluate the contributions of HLA–DQ and –DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and...
To evaluate the contributions of HLA-DQ and -DR polymorphisms to susceptibility to rheumatoid arthritis (RA) in a population in southern Spain, and to compare...
SourceID proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 307
SubjectTerms Alleles
Arthritis, Rheumatoid - epidemiology
Arthritis, Rheumatoid - genetics
Biological and medical sciences
Diseases of the osteoarticular system
Female
Genetic Predisposition to Disease
Histocompatibility Antigens Class II - genetics
HLA-DQ Antigens - genetics
HLA-DR Antigens - genetics
HLA-DR Serological Subtypes
HLA-DR1 Antigen - genetics
HLA-DR4 Antigen - genetics
Humans
Inflammatory joint diseases
Linkage Disequilibrium
Male
Medical sciences
Middle Aged
Spain - epidemiology
Title Rheumatoid arthritis in southern Spain: Toward elucidation of a unifying role of the HLA class II region in disease predisposition
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2F1529-0131%28200102%2944%3A2%3C307%3A%3AAID-ANR47%3E3.0.CO%3B2-K
https://www.ncbi.nlm.nih.gov/pubmed/11229460
https://www.proquest.com/docview/70639272
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1Lb9QwELaqHiokxPsRKOADleCQbWI7rwUhLUur3Za20tJKvVm246gRKFm6mwtHfgK_mJk42dWiXpAQx1iJx5qHPY4_f0PI6zhjoYVU19dYKEwYW_jKxJkfFJZpo62OA7yNfHIaTy7E0WV0uUW-93dhHD_E6ocbRkY7X2OAK73YX5OGwsKDSB8OAZ-ylhoN9s5CgGHZHh8jvJnjL-rR9JM_Op0JeDzgg2AwPtvjH5l_DLM2IrwwjZqtCacY73gr8bwgysIdknQS91fy3jhpb4UYsvcgZzhcyfjgJLyD_jfWudtztQCVF65Wxk3J7GZu3C5uh3fJr14tDtPyddAs9cD8-IMx8r_q7R6506XKdOR8-z7ZstUDsnPSgQEekp-zK9tAwl2XOYUAuGrpmWhZ0UXdwvYr-mWuympIz1toMLXfGlO6ElK0LqiiTVW2t7woQiyxCb6ik88janBLQadTimUr4G3oszvIovNrvMjcQ90ekYvDg_PxxO9KSviGZbAkWM2ttToPTRSYxCZ5muoQbwfjaWig0jQqAp5pyGGUCvMkiDSLucZdocpTzhP-mGxXdWWfElqkIsuRLS3PmTCF0DrJlI21MirOQ5V5ZNI7gJw75hDpOKKZRBtItIF0FpBCSCZB91KC3mWrd8llIMdn0H7skd0NB1r1l-H0HHrkVe9PEiYHPPFRla2bhUwwAWUJ88gT52brkYQMrB4HHjlqneUvhnjTCF3Ds3_Z2XNyy-H9EDq0S7aX1419AQngUr9sY_Y3vy49Pw
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1LaxsxEBZpCmmh9P1wmzY6NNAe1tmV5H24peA6CXb8CDgO5CYkrZaYhLWxvZce-xf6hzuzWtu45FIoPVp4NWIe0kj69A0hH8OEBRZSXU9joTBhbOYpEyaen1mmjbY69PE18mAYdi7F2VXjaofMV29hHD_E-sANI6OcrzHA8UD6aMMaCisPQn04RHzMSm402DwLAZZlh7yN-GaOZ9St7rHXGo4E_Dzhdb_ePj_k35nXu0fuYx1w5Ns_Hm0opxivmCvxxqCRBHskqkQerQV-cuI-C9FkX0FQs7kW8s2J-AICtla6RzO1AKVnrlrGXensdnZcLm-nT8ivlWIcquWmXix13fz4gzPy_2ruKXlcZcu05dz7Gdmx-XOyN6jwAC_Iz9G1LSDnnk5SCjFwXTI00UlOF9MSuZ_Ti5ma5E06LtHB1N4WZuKqSNFpRhUt8kn50IsiyhKb4Cva6beowV0F7XYpVq6Af0Of1V0Wnc3xLfMK7faSXJ6ejNsdr6oq4RmWwKpgNbfW6jQwDd9ENkrjWAf4QBgvRH0Vx43M54mGNEapII38hmYh17gxVGnMecRfkd18mts3hGaxSFIkTEtTJkwmtI4SZUOtjArTQCU10ll5gJw58hDpaKKZRBtItIF0FpBCSCZB91KC3mWpd8mlL9vn0N6rkf0tD1r3l-AMHdTIwcqhJMwPeOmjcjstFjLCHJRFrEZeOz_bjCRgYPXQr5Gz0lv-Yoh3jdA1vP2XnR2QB53xoC_73WHvHXno4H-IJNonu8t5Yd9DPrjUH8oA_g2w30Fb
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwvV1bb9MwFLbGkCokxP1SGMwPTIKHdInt5lIQUmlXtevWobJJe7Nsx9EqUFLW5oVHfgK_mHPitFXRXpAQj7ESH-tc7OP483cIeRMmLLCQ6noaC4UJYzNPmTDx_MwybbTVoY-3kU8n4fBCHF-2L3fI99VdGMcPsf7hhpFRzdcY4PM0O9yQhsLCg0gfDgEfs4oaDfbOQoBh2QHvIbyZ4y_q7qjvdSdTAY9HvOW3emcH_BPzxrfIbRH6CVZ76E83jFOM18SVeGDQToIGiWqRh2uBb524d0J02AcQ1OmshXx0It6DgK2F7u5cLUDnmSuWcVM2u50cV6vb4D75tdKLA7V8bZVL3TI__qCM_K-Ke0Du1bky7Trnfkh2bP6INE5rNMBj8nN6ZUvIuItZSiECrip-JjrL6aKocPs5_TJXs7xDzytsMLXfSjNzNaRokVFFy3xWXfOiiLHEJviKDk-61OCego5GFOtWwNvQZ32SRefXeJN5hXV7Qi4GR-e9oVfXlPAMS2BNsJpba3UamLZvIhulcawDvB6Mx6G-iuN25vNEQxKjVJBGfluzkGvcFqo05jziT8luXuT2OaFZLJIU6dLSlAmTCa2jRNlQK6PCNFBJkwxXDiDnjjpEOpJoJtEGEm0gnQWkEJJJ0L2UoHdZ6V1y6cveGbSPm2Rvy4HW_SU4PwdNsr_yJwmzAx75qNwW5UJGmIGyiDXJM-dmm5EEDKwe-k1yXDnLXwzxphG6hhf_srN90vjcH8iT0WT8ktxx2D-EEe2R3eV1aV9BMrjUr6vw_Q2LU0AK
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rheumatoid+arthritis+in+southern+Spain%3A+toward+elucidation+of+a+unifying+role+of+the+HLA+class+II+region+in+disease+predisposition&rft.jtitle=Arthritis+and+rheumatism&rft.au=Pascual%2C+M&rft.au=Nieto%2C+A&rft.au=L%C3%B3pez-Nevot%2C+M+A&rft.au=Ramal%2C+L&rft.date=2001-02-01&rft.issn=0004-3591&rft.volume=44&rft.issue=2&rft.spage=307&rft_id=info:doi/10.1002%2F1529-0131%28200102%2944%3A2%3C307%3A%3AAID-ANR47%3E3.0.CO%3B2-K&rft_id=info%3Apmid%2F11229460&rft.externalDocID=11229460
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon